{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:59:41Z","timestamp":1792159181826,"version":"4.4.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Probiotics &amp; Antimicro. Prot."],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s12602-025-10706-z","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T08:27:17Z","timestamp":1754987237000},"page":"2628-2638","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Probiotics and Diet Modifications: A Holistic Approach to Tackling Helicobacter pylori with the Help of the Gut Microbiota"],"prefix":"10.1007","volume":"18","author":[{"given":"Tamer A.","family":"Addissouky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuliang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim El Tantawy El","family":"Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naser A.","family":"Naser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Jalal AlAhmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,12]]},"reference":[{"key":"10706_CR1","doi-asserted-by":"publisher","unstructured":"Medakina I, Tsapkova L, Polyakova V, Nikolaev S, Yanova T, Dekhnich N et al (2023) Helicobacter pylori Antibiotic Resistance: Molecular Basis and Diagnostic Methods. Int J Mol Sci 24(11). https:\/\/doi.org\/10.3390\/ijms24119433","DOI":"10.3390\/ijms24119433"},{"key":"10706_CR2","doi-asserted-by":"publisher","unstructured":"Addissouky TA, Ali MMA, El Tantawy El Sayed I, Wang Y, El Baz A, Elarabany N et al (2023) Preclinical promise and clinical challenges for innovative therapies targeting liver fibrogenesis. Arch Gastroenterol Res 4(1):14\u201323. https:\/\/doi.org\/10.33696\/Gastroenterology.4.044","DOI":"10.33696\/Gastroenterology.4.044"},{"key":"10706_CR3","doi-asserted-by":"publisher","unstructured":"Pop R, T\u0103b\u0103ran F, Ungur AP, Negoescu A, C\u0103toi C (2022) Helicobacter pylori-Induced gastric infections: from pathogenesis to novel therapeutic approaches using silver nanoparticles. Pharmaceutics 14(7). https:\/\/doi.org\/10.3390\/pharmaceutics14071463","DOI":"10.3390\/pharmaceutics14071463"},{"key":"10706_CR4","doi-asserted-by":"publisher","unstructured":"Talebi Bezmin Abadi A, Perez-Perez G (2016) Role of\u00a0dupA\u00a0in virulence of\u00a0Helicobacter pylori. World J Gastroenterol 22(46):10118\u201310123. https:\/\/doi.org\/10.3748\/wjg.v22.i46.10118.","DOI":"10.3748\/wjg.v22.i46.10118"},{"key":"10706_CR5","doi-asserted-by":"publisher","first-page":"141","DOI":"10.4236\/ajmb.2023.133010","volume":"13","author":"T Compaore","year":"2023","unstructured":"Compaore T, Traore K, Compaore N, Traore L, Zida S, Soubeiga S et al (2023) Helicobacter pylori Virulence Genes cagA, babA2, and vacA Detection in Dyspeptic Patients from Burkina Faso. Am J Mol Biol 13:141\u2013155. https:\/\/doi.org\/10.4236\/ajmb.2023.133010","journal-title":"Am J Mol Biol"},{"issue":"11","key":"10706_CR6","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.3390\/healthcare11111658","volume":"11","author":"TC Nguyen","year":"2023","unstructured":"Nguyen TC, Tang NL, Le GK, Nguyen VT, Nguyen KH, Che TH, Phan, et al (2023) Helicobacter pylori Infection and Peptic Ulcer Disease in Symptomatic Children in Southern Vietnam: A Prospective Multicenter Study. Healthcare 11(11):1658. https:\/\/doi.org\/10.3390\/healthcare11111658","journal-title":"Healthcare"},{"key":"10706_CR7","doi-asserted-by":"publisher","unstructured":"Katsande PM, Nguyen VD, Phuong Nguyen TL, Cuc Nguyen TK, Mills G, D. Bailey DM, Christie G, Hong HA, Cutting SM (2023) Prophylactic immunization to Helicobacter pylori infection using spore vectored vaccines. Helicobacter e12997. https:\/\/doi.org\/10.1111\/hel.12997","DOI":"10.1111\/hel.12997"},{"issue":"3","key":"10706_CR8","doi-asserted-by":"publisher","first-page":"150","DOI":"10.5114\/pg.2016.61487","volume":"11","author":"\u0141 Ho\u0142ubiuk","year":"2016","unstructured":"Ho\u0142ubiuk \u0141, Imiela J (2016) Diet and Helicobacter pylori infection. Prz Gastroenterol. 11(3):150\u2013154. https:\/\/doi.org\/10.5114\/pg.2016.61487","journal-title":"Prz Gastroenterol."},{"issue":"16","key":"10706_CR9","doi-asserted-by":"publisher","first-page":"175628482311606","DOI":"10.1177\/17562848231160620","volume":"6","author":"GAS Soares","year":"2023","unstructured":"Soares GAS, Moraes FAS, Ramos AFPL, Santiago SB, Germano JN, Fernandes GA, Curado MP, Barbosa MS (2023) Dietary habits and Helicobacter pylori infection: is there an association? Therap Adv Gastroenterol 6(16):17562848231160620. https:\/\/doi.org\/10.1177\/17562848231160620","journal-title":"Therap Adv Gastroenterol"},{"key":"10706_CR10","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.2147\/IDR.S413416","volume":"16","author":"HA Habteweld","year":"2023","unstructured":"Habteweld HA, Asfaw T (2023) Novel Dietary Approach with Probiotics, Prebiotics, and Synbiotics to Mitigate Antimicrobial Resistance and Subsequent Out Marketplace of Antimicrobial Agents: A Review. Infect Drug Resist 16:3191\u20133211. https:\/\/doi.org\/10.2147\/IDR.S413416","journal-title":"Infect Drug Resist"},{"issue":"19","key":"10706_CR11","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.3390\/nu14194215","volume":"14","author":"F Habbash","year":"2022","unstructured":"Habbash F, Alalwan TA, Perna S, Ahmed N, Sharif O, Al Sayyad A, Gasparri C, Ferraris C, Rondanelli M (2022) Association between Dietary Habits and Helicobacter pylori Infection among Bahraini Adults. Nutrients 14(19):4215. https:\/\/doi.org\/10.3390\/nu14194215","journal-title":"Nutrients"},{"key":"10706_CR12","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s43088-023-00417-1","volume":"12","author":"TA Addissouky","year":"2023","unstructured":"Addissouky TA, Wang Y, El Sayed IE et al (2023) Recent trends in Helicobacter pylori management: harnessing the power of AI and other advanced approaches. Beni-Suef Univ J Basic Appl Sci 12:80. https:\/\/doi.org\/10.1186\/s43088-023-00417-1","journal-title":"Beni-Suef Univ J Basic Appl Sci"},{"issue":"1","key":"10706_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-023-00431-8","volume":"9","author":"P Malfertheiner","year":"2023","unstructured":"Malfertheiner P, Camargo MC, Liou J, Peek R, Schulz C, Smith SI, Suerbaum S (2023) Helicobacter pylori infection. Nat Rev Dis Primers 9(1):1\u201324. https:\/\/doi.org\/10.1038\/s41572-023-00431-8","journal-title":"Nat Rev Dis Primers"},{"key":"10706_CR14","doi-asserted-by":"publisher","unstructured":"Talebi Bezmin Abadi, Amin, Yoshio Yamaoka (2018) Helicobacter pylori Therapy and clinical perspective. J Global Antimicrobial Resist 14:111\u2013117. Accessed 22 Dec 2023. https:\/\/doi.org\/10.1016\/j.jgar.2018.03.005.","DOI":"10.1016\/j.jgar.2018.03.005"},{"key":"10706_CR15","doi-asserted-by":"publisher","unstructured":"Sotirios\u00a0Georgopoulos\u00a0&\u00a0Vasilios\u00a0Papastergiou\u00a0(2021)\u00a0An update on current and advancing pharmacotherapy options for the treatment of H. pylori infection.\u00a0Expert Opin Pharmacother 22(6):729\u2013741,\u00a0https:\/\/doi.org\/10.1080\/14656566.2020.1845649","DOI":"10.1080\/14656566.2020.1845649"},{"key":"10706_CR16","doi-asserted-by":"publisher","unstructured":"Addissouky TA, Ali MMA, El Tantawy El Sayed I, Wang Y (2023) Recent advances in diagnosing and treating Helicobacter pylori through botanical extracts and advanced technologies. Arch Pharmacol Ther 5(1):53\u201366. https:\/\/doi.org\/10.33696\/Pharmacol.4.045","DOI":"10.33696\/Pharmacol.4.045"},{"key":"10706_CR17","doi-asserted-by":"publisher","first-page":"3277","DOI":"10.2147\/IDR.S371113","volume":"15","author":"C Gao","year":"2022","unstructured":"Gao C, Fan H (2022) Effect and Safety of Helicobacter pylori Eradication Treatment Based on Molecular Pathologic Antibiotic Resistance in Chinese Elderly People. Infect Drug Resist 15:3277\u20133286. https:\/\/doi.org\/10.2147\/IDR.S371113","journal-title":"Infect Drug Resist"},{"issue":"4","key":"10706_CR18","doi-asserted-by":"publisher","first-page":"552","DOI":"10.3390\/ph16040552","volume":"16","author":"A Sukri","year":"2023","unstructured":"Sukri A, Hanafiah A, Patil S, Lopes BS (2023) The Potential of Alternative Therapies and Vaccine Candidates against Helicobacter pylori. Pharmaceuticals 16(4):552. https:\/\/doi.org\/10.3390\/ph16040552","journal-title":"Pharmaceuticals"},{"issue":"5","key":"10706_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2023.102125","volume":"47","author":"D Liu","year":"2023","unstructured":"Liu D, Wang Q, Li P, Wu D, Pan J, Chen Z, Li Y, Han X, Lan C, Tang J, Tan Y, Mo C, Yang W, Han J, Huang X (2023) Comparing high-dose dual therapy with bismuth-containing quadruple therapy for the initial eradication of Helicobacter pylori infection on Hainan Island: A randomized, multicenter clinical trial. Clin Res Hepatol Gastroenterol 47(5):102125. https:\/\/doi.org\/10.1016\/j.clinre.2023.102125","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"2","key":"10706_CR20","doi-asserted-by":"publisher","first-page":"244","DOI":"10.22080\/jgr.2022.23949.1324","volume":"8","author":"M Alipour","year":"2022","unstructured":"Alipour M, Mofarrah R (2022) Probiotics for Treatment of Helicobacter pylori Infections and Gastric Cancer Prevention. J Gen Resour 8(2):244\u2013254. https:\/\/doi.org\/10.22080\/jgr.2022.23949.1324","journal-title":"J Gen Resour"},{"key":"10706_CR21","doi-asserted-by":"publisher","unstructured":"Daniela Guadalupe Lucio-Sauceda, V\u00edctor Hugo Urrutia-Baca, Ricardo Gomez-Flores, Myriam Ang\u00e9lica De La Garza-Ramos, Patricia Tamez-Guerra, Alonso Orozco-Flores (2019) Antimicrobial and Anti-Biofilm Effect of an Electrolyzed Superoxidized Solution at Neutral-pH against\u00a0Helicobacter pylori. BioMed Res Int 2019(9):61548679. https:\/\/doi.org\/10.1155\/2019\/6154867","DOI":"10.1155\/2019\/6154867"},{"key":"10706_CR22","doi-asserted-by":"publisher","first-page":"1211259","DOI":"10.3389\/fmicb.2023.1211259","volume":"14","author":"Q Lin","year":"2023","unstructured":"Lin Q, Hao W, Zhou R, Huang C, Wang X, Liu Y, Li X (2023) Pretreatment with Bifidobacterium longum BAA2573 ameliorates dextran sulfate sodium (DSS)-induced colitis by modulating gut microbiota. Front Microbiol 14:1211259. https:\/\/doi.org\/10.3389\/fmicb.2023.1211259","journal-title":"Front Microbiol"},{"issue":"21","key":"10706_CR23","doi-asserted-by":"publisher","first-page":"13646","DOI":"10.3390\/ijms232113646","volume":"23","author":"L Zhang","year":"2022","unstructured":"Zhang L, Chen X, Ren B, Zhou X, Cheng L (2022) Helicobacter pylori in the Oral Cavity: Current Evidence and Potential Survival Strategies. Int J Mol Sci 23(21):13646. https:\/\/doi.org\/10.3390\/ijms232113646","journal-title":"Int J Mol Sci"},{"key":"10706_CR24","doi-asserted-by":"publisher","unstructured":"Qu P, Liu X, Xia X, Xie X, Luo J, Cheng S, Chi J, Liu P, Li H, Zhao W, Yang H, Xu C (2022) Saccharomyces boulardii allows partial patients to avoid reusing bismuth quadruple for Helicobacter pylori rescue therapy: A single-center randomized controlled study. Front Cell Infect Microbiol 12. https:\/\/doi.org\/10.3389\/fcimb.2022.903002","DOI":"10.3389\/fcimb.2022.903002"},{"issue":"2","key":"10706_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.afres.2022.100185","volume":"2","author":"TK Das","year":"2022","unstructured":"Das TK, Pradhan S, Chakrabarti S, Mondal KC, Ghosh K (2022) Current status of probiotic and related health benefits. Appl Food Res 2(2):100185. https:\/\/doi.org\/10.1016\/j.afres.2022.100185","journal-title":"Appl Food Res"},{"key":"10706_CR26","doi-asserted-by":"publisher","unstructured":"Fakharian F, Asgari B, Nabavi-Rad A, Sadeghi A, Soleimani N, Yadegar A, Zali MR (2022) The interplay between Helicobacter pylori and the gut microbiota: An emerging driver influencing the immune system homeostasis and gastric carcinogenesis. Front Cell Infect Microbiol 12. https:\/\/doi.org\/10.3389\/fcimb.2022.953718","DOI":"10.3389\/fcimb.2022.953718"},{"key":"10706_CR27","doi-asserted-by":"crossref","unstructured":"Ralser\u00a0A,\u00a0Dietl\u00a0A,\u00a0Jarosch\u00a0S, et al (2023)\u00a0Helicobacter pylori\u00a0promotes colorectal carcinogenesis by deregulating intestinal immunity and inducing a mucus-degrading microbiota signature. Gut\u00a072:1258\u20131270.","DOI":"10.1136\/gutjnl-2022-328075"},{"key":"10706_CR28","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-050476","volume":"13","author":"X Cao","year":"2023","unstructured":"Cao X, Yang Y, Zhang Y et al (2023) Impact of Helicobacter pylori on the gastric microbiome in patients with chronic gastritis: a systematic review and meta-analysis protocol. BMJ Open 13:e050476. https:\/\/doi.org\/10.1136\/bmjopen-2021-050476","journal-title":"BMJ Open"},{"key":"10706_CR29","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13099-022-00510-3","volume":"14","author":"T Sugihartono","year":"2022","unstructured":"Sugihartono T, Fauzia KA, Miftahussurur M et al (2022) Analysis of gastric microbiota and Helicobacter pylori infection in gastroesophageal reflux disease. Gut Pathog 14:38. https:\/\/doi.org\/10.1186\/s13099-022-00510-3","journal-title":"Gut Pathog"},{"key":"10706_CR30","doi-asserted-by":"publisher","unstructured":"Xu W, Xu L, Xu C (2022) Relationship between Helicobacter pylori infection and gastrointestinal microecology. Front Cell Infect Microbiol 12. https:\/\/doi.org\/10.3389\/fcimb.2022.938608","DOI":"10.3389\/fcimb.2022.938608"},{"key":"10706_CR31","doi-asserted-by":"publisher","unstructured":"Koo JK, Kim CH, Choe TB (1999) Inhibition of growth and adhesion of Helicobacter pylori\u00a0using egg yolk antibodies.\u00a0Biotechnol Bioprocess Eng\u00a04:219\u2013223. https:\/\/doi.org\/10.1007\/BF02931933","DOI":"10.1007\/BF02931933"},{"key":"10706_CR32","doi-asserted-by":"publisher","unstructured":"Hang Y, Bing H (2022) Immunological Perspective:\u00a0Helicobacter pylori\u00a0Infection and Gastritis. Mediat Inflam 2022(11):2944156. https:\/\/doi.org\/10.1155\/2022\/2944156","DOI":"10.1155\/2022\/2944156"},{"key":"10706_CR33","doi-asserted-by":"publisher","unstructured":"Chen X, Wang N, Wang J, Liao B, Cheng L, Ren B (2022) The interactions between oral-gut axis microbiota and Helicobacter pylori. Front Cell Infect Microbiol 12. https:\/\/doi.org\/10.3389\/fcimb.2022.914418","DOI":"10.3389\/fcimb.2022.914418"},{"issue":"14","key":"10706_CR34","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.3748\/wjg.v29.i14.2202","volume":"29","author":"FF Bueno Lemos","year":"2023","unstructured":"Bueno Lemos FF, Calmon MS, Luz MS, Rocha Pinheiro SL, Correa Santos GL, Marques HS, Delgado HA, Teixeira KN, Souza CL, Oliveira MV (2023) Effectiveness of Helicobacter pylori eradication in the treatment of early-stage gastric mucosa-associated lymphoid tissue lymphoma: An up-to-date meta-analysis. World J Gastroenterol 29(14):2202\u20132221. https:\/\/doi.org\/10.3748\/wjg.v29.i14.2202","journal-title":"World J Gastroenterol"},{"key":"10706_CR35","doi-asserted-by":"publisher","first-page":"1042070","DOI":"10.3389\/fcimb.2022.1042070","volume":"12","author":"B Liang","year":"2022","unstructured":"Liang B, Yuan Y, Peng X, Liu X, Hu X, Xing D (2022) Current and future perspectives for Helicobacter pylori treatment and management: From antibiotics to probiotics. Front Cell Infect Microbiol 12:1042070. https:\/\/doi.org\/10.3389\/fcimb.2022.1042070","journal-title":"Front Cell Infect Microbiol"},{"key":"10706_CR36","doi-asserted-by":"publisher","first-page":"1120789","DOI":"10.3389\/fcimb.2023.1120789","volume":"13","author":"Y Wang","year":"2023","unstructured":"Wang Y, Wang X, Cao X, Zhu H, Miao L (2023) Comparative effectiveness of different probiotics supplements for triple helicobacter pylori eradication: A network meta-analysis. Front Cell Infect Microbiol 13:1120789. https:\/\/doi.org\/10.3389\/fcimb.2023.1120789","journal-title":"Front Cell Infect Microbiol"},{"key":"10706_CR37","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12866-023-02782-4","volume":"23","author":"Z Yu","year":"2023","unstructured":"Yu Z, Cao M, Peng J et al (2023) Lacticaseibacillus casei T1 attenuates Helicobacter pylori-induced inflammation and gut microbiota disorders in mice. BMC Microbiol 23:39. https:\/\/doi.org\/10.1186\/s12866-023-02782-4","journal-title":"BMC Microbiol"},{"issue":"1","key":"10706_CR38","doi-asserted-by":"publisher","first-page":"122","DOI":"10.4162\/nrp.2023.17.1.122","volume":"17","author":"JH Kwak","year":"2023","unstructured":"Kwak JH, Eun CS, Han DS, Kim YS, Song KS, Choi BY, Kim HJ (2023) Association between soy products, fruits, vegetables, and dairy products and gastric cancer risk in Helicobacter pylori-infected subjects: A case-control study in Korea. Nurs Res Pract 17(1):122\u2013134. https:\/\/doi.org\/10.4162\/nrp.2023.17.1.122","journal-title":"Nurs Res Pract"},{"issue":"9","key":"10706_CR39","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.4251\/wjgo.v14.i9.1689","volume":"14","author":"D Pan","year":"2022","unstructured":"Pan D, Sun J, Su M, Wang X, Yan Y, Song G, Wang Y, Xu F, Wang N, Wang K (2022) Inverse relations between Helicobacter pylori infection and risk of esophageal precancerous lesions in drinkers and peanut consumption. World J Gastrointest Oncol 14(9):1689\u20131698. https:\/\/doi.org\/10.4251\/wjgo.v14.i9.1689","journal-title":"World J Gastrointest Oncol"},{"key":"10706_CR40","doi-asserted-by":"publisher","first-page":"1139800","DOI":"10.3389\/fcimb.2023.1139800","volume":"13","author":"S Fan","year":"2023","unstructured":"Fan S, Chen S, Lin L (2023) Research progress of gut microbiota and obesity caused by high-fat diet. Front Cell Infect Microbiol 13:1139800. https:\/\/doi.org\/10.3389\/fcimb.2023.1139800","journal-title":"Front Cell Infect Microbiol"},{"key":"10706_CR41","doi-asserted-by":"publisher","first-page":"1002359","DOI":"10.3389\/fnut.2023.1002359","volume":"10","author":"J Zhang","year":"2023","unstructured":"Zhang J, Hai X, Wang S, Zhu F, Gu Y, Meng G, Zhang Q, Liu L, Wu H, Zhang S, Zhang T, Wang X, Sun S, Zhou M, Jia Q, Song K, Niu K (2023) Helicobacter pylori infection increase the risk of subclinical hyperthyroidism in middle-aged and elderly women independent of dietary factors: Results from the Tianjin chronic low-grade systemic inflammation and health cohort study in China. Front Nutr 10:1002359. https:\/\/doi.org\/10.3389\/fnut.2023.1002359","journal-title":"Front Nutr"},{"key":"10706_CR42","doi-asserted-by":"publisher","unstructured":"R\u00eago A, Guedes Silvestre GF, Albino SL, Pimentel MM, Silva Costa Cruz SB, Silva Wurzba SD, Rodrigues WF, Damasceno L, Can\u00e7ado Castellano LR (2022) Flavonoids-Rich Plant Extracts Against Helicobacter pylori Infection as Prevention to Gastric Cancer. Front Pharmacol 13. https:\/\/doi.org\/10.3389\/fphar.2022.951125","DOI":"10.3389\/fphar.2022.951125"},{"key":"10706_CR43","doi-asserted-by":"publisher","unstructured":"Ali Nabavi-Rad, Mahsa Azizi, Shaghayegh Jamshidizadeh, Amir Sadeghi, Hamid Asadzadeh Aghdaei, Abbas Yadegar, Mohammad Reza Zali (2022) The Effects of vitamins and micronutrients on\u00a0Helicobacter pylori\u00a0Pathogenicity, Survival, and Eradication: A Crosstalk between Micronutrients and Immune System. J Immunol Res 2022(22):4713684. https:\/\/doi.org\/10.1155\/2022\/4713684","DOI":"10.1155\/2022\/4713684"},{"key":"10706_CR44","doi-asserted-by":"publisher","unstructured":"Ballini A, Charitos IA, Cantore S, Topi S, Bottalico L, Santacroce L (2023) About functional foods: The probiotics and prebiotics state of art. Antibiotics 12(4). https:\/\/doi.org\/10.3390\/antibiotics12040635","DOI":"10.3390\/antibiotics12040635"},{"key":"10706_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2022.12.015","author":"M John Kenneth","year":"2022","unstructured":"John Kenneth M, Tsai H, Fang C, Hussain B, Chiu Y, Hsu B (2022) Diet-mediated gut microbial community modulation and signature metabolites as potential biomarkers for early diagnosis, prognosis, prevention and stage-specific treatment of colorectal cancer. J Adv Res. https:\/\/doi.org\/10.1016\/j.jare.2022.12.015","journal-title":"J Adv Res"},{"issue":"2","key":"10706_CR46","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3390\/fermentation9020118","volume":"9","author":"AM Shah","year":"2023","unstructured":"Shah AM, Tarfeen N, Mohamed H, Song Y (2023) Fermented Foods: Their Health-Promoting Components and Potential Effects on Gut Microbiota. Fermentation 9(2):118. https:\/\/doi.org\/10.3390\/fermentation9020118","journal-title":"Fermentation"},{"issue":"1","key":"10706_CR47","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-062932.PMID:36604137;PMCID:PMC9827256","volume":"13","author":"Q Wang","year":"2023","unstructured":"Wang Q, Yao C, Li Y, Luo L, Xie F, Xiong Q, Feng P (2023) Effect of polyphenol compounds on Helicobacter pylori eradication: a systematic review with meta-analysis. BMJ Open 13(1):e062932. https:\/\/doi.org\/10.1136\/bmjopen-2022-062932.PMID:36604137;PMCID:PMC9827256","journal-title":"BMJ Open"},{"key":"10706_CR48","doi-asserted-by":"publisher","unstructured":"Xie J, Cools L, Imschoot GV, Wonterghem EV, Pauwels MJ, Vlaeminck I, Witte CD, Andaloussi SE, Wierda K, Groef LD, Haesebrouck F, Hoecke LV, Vandenbroucke RE (2023) Helicobacter pylori\u2010derived outer membrane vesicles contribute to Alzheimer's disease pathogenesis via C3\u2010C3aR signalling. J Extracell Vesicles 12(2). https:\/\/doi.org\/10.1002\/jev2.12306","DOI":"10.1002\/jev2.12306"},{"issue":"1","key":"10706_CR49","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/onco3010003","volume":"3","author":"P Helisz","year":"2023","unstructured":"Helisz P, Gwio\u017adzik W, Grajek M, S\u0142owi\u0144ski J (2023) Risk Factors and Prevention of Gastric Cancer Development\u2014What Do We Know and What Can We Do? Onco 3(1):26\u201342. https:\/\/doi.org\/10.3390\/onco3010003","journal-title":"Onco"},{"key":"10706_CR50","doi-asserted-by":"publisher","unstructured":"Sathianarayanan S, Ammanath AV, Biswas R, B A, Sukumaran S, Venkidasamy B (2022) A new approach against Helicobacter pylori using plants and its constituents: A review study. Microbial Pathogenesis 168:105594. https:\/\/doi.org\/10.1016\/j.micpath.2022.105594","DOI":"10.1016\/j.micpath.2022.105594"},{"key":"10706_CR51","doi-asserted-by":"publisher","first-page":"1130001","DOI":"10.3389\/fmicb.2023.1130001","volume":"14","author":"S Zhou","year":"2023","unstructured":"Zhou S, Li C, Liu L, Yuan Q, Miao J, Wang H, Ding C, Guan W (2023) Gastric microbiota: An emerging player in gastric cancer. Front Microbiol 14:1130001. https:\/\/doi.org\/10.3389\/fmicb.2023.1130001","journal-title":"Front Microbiol"},{"key":"10706_CR52","doi-asserted-by":"publisher","first-page":"1049279","DOI":"10.3389\/fcimb.2022.1049279","volume":"12","author":"Y Hu","year":"2022","unstructured":"Hu Y, Zhu Y, Lu N (2022) The management of Helicobacter pylori infection and prevention and control of gastric cancer in China. Front Cell Infect Microbiol 12:1049279. https:\/\/doi.org\/10.3389\/fcimb.2022.1049279","journal-title":"Front Cell Infect Microbiol"},{"issue":"18","key":"10706_CR53","doi-asserted-by":"publisher","first-page":"10941","DOI":"10.3390\/ijms231810941","volume":"23","author":"J Zeng","year":"2022","unstructured":"Zeng J, Xie C, Zhang L, Liu X, Chan MT, Wu WK, Chen H (2022) Host Cell Antimicrobial Responses against Helicobacter pylori Infection: From Biological Aspects to Therapeutic Strategies. Int J Mol Sci 23(18):10941. https:\/\/doi.org\/10.3390\/ijms231810941","journal-title":"Int J Mol Sci"},{"key":"10706_CR54","doi-asserted-by":"publisher","unstructured":"Addissouky TA; El Tantawy El Sayed I, Ali MMA, Wang Y, El Baz A, Khalil AA et al (2023) Latest advances in hepatocellular carcinoma management and prevention through advanced technologies.\u00a0Egyptian Liver J 13:71. https:\/\/doi.org\/10.1186\/s43066-023-00306-3","DOI":"10.1186\/s43066-023-00306-3"},{"key":"10706_CR55","doi-asserted-by":"publisher","first-page":"1092342","DOI":"10.3389\/fnut.2023.1092342","volume":"10","author":"A Taibi","year":"2023","unstructured":"Taibi A, Lofft Z, Comelli EM (2023) The role of intestinal microbiota and microRNAs in the anti-inflammatory effects of cranberry: From pre-clinical to clinical studies. Front Nutr 10:1092342. https:\/\/doi.org\/10.3389\/fnut.2023.1092342","journal-title":"Front Nutr"},{"issue":"2","key":"10706_CR56","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.21608\/ejhm.2023.286004","volume":"90","author":"DM Mohamed","year":"2023","unstructured":"Mohamed DM, Elrassas H (2023) Helicobacter pylori Associated Depression among Patients Presenting with Epigastric Pain. Egyptian J Hospital Med 90(2):2315\u20132320","journal-title":"Egyptian J Hospital Med"},{"issue":"6","key":"10706_CR57","doi-asserted-by":"publisher","first-page":"5776","DOI":"10.3390\/ijms24065776","volume":"24","author":"P Di Fermo","year":"2023","unstructured":"Di Fermo P, Di Lodovico S, Di Campli E, Diban F, Di Giulio M, Cellini L (2023) Helicobacter pylori Dormant States Are Affected by Vitamin C. Int J Mol Sci 24(6):5776. https:\/\/doi.org\/10.3390\/ijms24065776","journal-title":"Int J Mol Sci"},{"key":"10706_CR58","doi-asserted-by":"publisher","unstructured":"Allen MG, Bate MY, Tramonte LM, Avalos EY, Loh J, Cover TL, Forsyth MH (2023) Regulation of Helicobacter pylori Urease and Acetone Carboxylase Genes by Nitric Oxide and the CrdRS Two-Component System. Microbiol Spectrum 11(1). https:\/\/doi.org\/10.1128\/spectrum.04633-22","DOI":"10.1128\/spectrum.04633-22"},{"key":"10706_CR59","doi-asserted-by":"publisher","unstructured":"Abdulfattah AA, Jawkhab HA, Alhazmi AA et al (2023) The association of smoking and coffee consumption with occurrence of upper gastrointestinal symptoms in patients with active Helicobacter pylori infection in Jazan City: a cross-sectional study. Cureus 15(1):e33574. https:\/\/doi.org\/10.7759\/cureus.33574","DOI":"10.7759\/cureus.33574"},{"key":"10706_CR60","doi-asserted-by":"publisher","unstructured":"Dawkins YM, Rowe-Gardener S, Guthrie-Dixon N, Thompson R, Thompson T, Lee MG, Cunningham-Myrie C (2023) H. pylori predictors and outcomes among adults undergoing upper endoscopy at a Jamaican teaching hospital: a cross-sectional study. Helicobacter 28(3):e12968. https:\/\/doi.org\/10.1111\/hel.12968","DOI":"10.1111\/hel.12968"},{"key":"10706_CR61","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1186\/s12885-022-09894-6","volume":"22","author":"HX Le","year":"2022","unstructured":"Le HX, Truong DTT, Tran LB et al (2022) A prospective cohort study on the association between waterpipe tobacco smoking and gastric cancer mortality in Northern Vietnam. BMC Cancer 22:803. https:\/\/doi.org\/10.1186\/s12885-022-09894-6","journal-title":"BMC Cancer"},{"key":"10706_CR62","doi-asserted-by":"publisher","unstructured":"Quach DT, Mai BH, Tran MK, Dao LV, Tran HV, Vu KT et al (2022) Vietnam Association of Gastroenterology (VNAGE) consensus on the management of Helicobacter pylori infection. Front Med 9. https:\/\/doi.org\/10.3389\/fmed.2022.1065045","DOI":"10.3389\/fmed.2022.1065045"},{"key":"10706_CR63","doi-asserted-by":"publisher","unstructured":"Birato YC, Masimango BA, Katabana DM, Delphin M, Shindano TA (2023) Risk factors of Helicobacter pylori infection in Bukavu, Democratic Republic of the Congo: a case\u2013control study. Annal Med Surg 85(4):727\u2013731. https:\/\/doi.org\/10.1097\/MS9.0000000000000409","DOI":"10.1097\/MS9.0000000000000409"},{"issue":"11","key":"10706_CR64","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1002\/jgh3.12842","volume":"6","author":"JP Schubert","year":"2022","unstructured":"Schubert JP, Rayner CK, Costello SP, Roberts-Thomson IC, Forster SC, Bryant RV (2022) Helicobacter pylori: Have potential benefits been overlooked? JGH Open 6(11):735\u2013737. https:\/\/doi.org\/10.1002\/jgh3.12842","journal-title":"JGH Open"},{"issue":"7","key":"10706_CR65","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24885","volume":"37","author":"Y Lin","year":"2023","unstructured":"Lin Y, Shao Y, Yan J, Ye G (2023) Antibiotic resistance in Helicobacter pylori: From potential biomolecular mechanisms to clinical practice. J Clin Lab Anal 37(7):e24885. https:\/\/doi.org\/10.1002\/jcla.24885","journal-title":"J Clin Lab Anal"},{"key":"10706_CR66","doi-asserted-by":"publisher","first-page":"1128497","DOI":"10.3389\/fmicb.2023.1128497","volume":"14","author":"RI Dasc\u0103lu","year":"2023","unstructured":"Dasc\u0103lu RI, Bolocan A, P\u0103duaru DN, Constantinescu A, Mitache MM, Stoica AD, Andronic O (2023) Multidrug resistance in Helicobacter pylori infection. Front Microbiol 14:1128497. https:\/\/doi.org\/10.3389\/fmicb.2023.1128497","journal-title":"Front Microbiol"},{"issue":"1","key":"10706_CR67","doi-asserted-by":"publisher","first-page":"34","DOI":"10.7704\/kjhugr.2022.0051","volume":"23","author":"NR Lim","year":"2023","unstructured":"Lim NR, Choi SY, Chung WC (2023) Probiotic Supplementation for Treatment of Helicobacter pylori Infection: A Double-Blind Randomized Clinical Trial. Korean J Helicobacter Upper Gastrointest Res 23(1):34\u201341. https:\/\/doi.org\/10.7704\/kjhugr.2022.0051","journal-title":"Korean J Helicobacter Upper Gastrointest Res"},{"key":"10706_CR68","doi-asserted-by":"publisher","first-page":"1033063","DOI":"10.3389\/fimmu.2022.1033063","volume":"13","author":"C He","year":"2022","unstructured":"He C, Xie Y, Zhu Y, Zhuang K, Huo L, Yu Y, Guo Q, Shu X, Xiong Z, Zhang Z, Lyu B, Lu N (2022) Probiotics modulate gastrointestinal microbiota after Helicobacter pylori eradication: A multicenter randomized double-blind placebo-controlled trial. Front Immunol 13:1033063. https:\/\/doi.org\/10.3389\/fimmu.2022.1033063","journal-title":"Front Immunol"},{"key":"10706_CR69","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1007\/s00203-022-03314-w","volume":"204","author":"X Bai","year":"2022","unstructured":"Bai X, Zhu M, He Y et al (2022) The impacts of probiotics in eradication therapy of Helicobacter pylori. Arch Microbiol 204:692. https:\/\/doi.org\/10.1007\/s00203-022-03314-w","journal-title":"Arch Microbiol"},{"key":"10706_CR70","doi-asserted-by":"publisher","unstructured":"Addissouky TA, El Tantawy El Sayed I, Ali MMA, Wang Y, El Baz A, Khalil AA et al (2023) Can vaccines stop cancer before it starts? Assessing the promise of prophylactic immunization against high-risk preneoplastic lesions. J Cell Immunol 5(4):127\u2013126. https:\/\/doi.org\/10.33696\/immunology.5.178","DOI":"10.33696\/immunology.5.178"},{"issue":"1","key":"10706_CR71","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/jgh3.12843","volume":"7","author":"N Aumpan","year":"2023","unstructured":"Aumpan N, Mahachai V (2023) Management of Helicobacter pylori infection. JGH Open 7(1):3\u201315. https:\/\/doi.org\/10.1002\/jgh3.12843","journal-title":"JGH Open"}],"container-title":["Probiotics and Antimicrobial Proteins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-025-10706-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12602-025-10706-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-025-10706-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T09:00:03Z","timestamp":1774342803000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12602-025-10706-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,12]]},"references-count":71,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10706"],"URL":"https:\/\/doi.org\/10.1007\/s12602-025-10706-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3139132\/v1","asserted-by":"object"}]},"ISSN":["1867-1306","1867-1314"],"issn-type":[{"value":"1867-1306","type":"print"},{"value":"1867-1314","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,12]]},"assertion":[{"value":"29 July 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.\u00a0Consent for Publi","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not Applicable.\u00a0","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of\u00a0Interest"}}]}}